Biorasi’s subject matter experts can keep you ahead of the curve, freeing your team to focus on creating new therapeutics and saving lives.
When you need a clinical trial expert, on call, at your service
Trial complexity is increasing at a rapid pace, and the services offered by traditional CROs are not keeping pace. Biorasi’s consulting group is comprised of cross-disciplinary subject matter experts, including regulatory professionals, doctors, scientists, legal experts, and experienced clinical teams that work in tightly integrated groups to build better clinical development programs.
Biorasi’s consulting services are built around the idea that while individual trials and projects are important, ultimately they need to be part of an optimized and effective drug development program. We look at your projects in a global context, both figuratively and literally, and help you identify which pieces can be improved for success not just tomorrow, but a month or year or decade from now. Whether you need a quick answer to a CMC question or a specific regulatory requirement; a comprehensive clinical development plan or a study rescue assessment, Biorasi is ready to provide you with the resources you need.
"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."VP of Global Clinical Development, Top Specialty Pharma
Latest News and Blogs
Type 1 diabetes affects millions of people in the US alone. What’s worse is that the majority of patients do not achieve good control of their blood glucose levels. Management of type 1 diabetes has traditionally been cumbersome, time-consuming, and expensive, so...
In the clinical trial world, we spend a lot of time focusing on phase I-IV trials, and it’s easy to forget about the very important preclinical, basic science studies that go into drug development. Many pharmaceuticals are developed from basic science studies, or...